Virginia Retirement Systems’s Beam Therapeutics BEAM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.31M Buy
38,131
+800
+2% +$24.2K 0.01% 662
2026
Q1
$890K Sell
37,331
-2,200
-6% -$61K 0.01% 624
2025
Q4
$1.1M Sell
39,531
-2,300
-5% -$58.7K 0.01% 553
2025
Q3
$1.02M Buy
41,831
+100
+0.2% +$1.99K 0.01% 593
2025
Q2
$710K Buy
41,731
+3,700
+10% +$64.4K ﹤0.01% 675
2025
Q1
$743K Buy
+38,031
New +$996K 0.01% 643
2023
Q3
$399K Buy
16,600
+700
+4% +$18.8K ﹤0.01% 759
2023
Q2
$508K Buy
15,900
+300
+2% +$9.74K ﹤0.01% 717
2023
Q1
$478K Buy
15,600
+10,000
+179% +$395K ﹤0.01% 756
2022
Q4
$219K Sell
5,600
-2,900
-34% -$130K ﹤0.01% 1036
2022
Q3
$405K Buy
+8,500
New +$485K ﹤0.01% 862

Other funds holding BEAM

Virginia Retirement Systems's BEAM Position: Q2 2026 in Review

Virginia Retirement Systems increased its Beam Therapeutics (BEAM) stake by 2.1% in Q2 2026, buying an estimated $24.2K and bringing the position to 38,131 shares worth $1.31M. The position accounts for 0.01% of the portfolio, ranked #662.

Virginia Retirement Systems first reported a position in BEAM in Q3 2022 and has held it in 11 quarters since. 277 funds tracked by Wall St. Rank hold BEAM as of Q2 2026.

  • Virginia Retirement Systems held 38,131 shares of Beam Therapeutics worth $1.31M as of Q2 2026.
  • Virginia Retirement Systems bought 800 Beam Therapeutics shares in Q2 2026, an estimated $24.2K.
  • Beam Therapeutics made up 0.01% of Virginia Retirement Systems's portfolio in Q2 2026, its #662 holding.
  • Virginia Retirement Systems first reported a position in Beam Therapeutics in Q3 2022 and has held it in 11 quarters since.
  • 277 funds tracked by Wall St. Rank held Beam Therapeutics as of Q2 2026.

Based on Virginia Retirement Systems's 13F filing for Q2 2026, filed 25 Aug 2026.